C57BL/6JNifdc-B2mtm1(B2M/HLA-A68.1/H2-D)Bcgen/Bcgen • 114304
| Product name | B-HLA-A68.1 mice |
|---|---|
| Catalog number | 114304 |
| Strain name | C57BL/6JNifdc-B2mtm1(B2M/HLA-A68.1/H2-D)Bcgen/Bcgen |
| Strain background | C57BL/6JNifdc |
| NCBI gene ID | 3105 (Mouse) |
| Aliases | HLAA |
Gene targeting strategy for B-HLA-A68.1 mice. The B2M gene (Exon1 to Exon3) of mouse was replaced by the sequence encompassing the human B2M CDS and HLA-A*6801 gene that included leader sequence, α1 and α2 domains ligated to a fragment of the murine H-2Db gene containing the α3, transmembrane and cytoplasmic domains.
Strain specific B2M and HLA-A68.1 expression analysis in wild-type C57BL/6JNifdc mice and heterozygous humanized B-HLA-A68.1 mice by flow cytometry. Splenocytes were collected from wild-type C57BL/6JNifdc mice (+/+) and heterozygous B-HLA-A68.1 mice (H/+), respectively, and analyzed by flow cytometry with species-specific anti-HLA-A68.1 antibody (Biolegend, 311406), anti-H-2Db antibody (Biolegend, 111513), anti-hB2M antibody (Biolegend, 395712), and anti-mB2M antibody (BD Biosciences, 744802) antibody. HLA-A68.1 and human B2M were exclusively detectable in heterozygous B-HLA-A68.1 mice.